Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 745 All time
- Disclosed funding
- $25.4B 610 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| D DoctronicCompany profile Provides AI-powered personalized health insights and connects users to licensed providers instantly Provides AI-powered personalized health insights and connects users to licensed providers instantly | $40M | Series B | Healthtech | United States | Investors | |
| N NanoZymeXCompany profile NanoZymeX develops a lipid-nanoparticle platform for enzyme replacement therapy. NanoZymeX develops a lipid-nanoparticle platform for enzyme replacement therapy. | €160K | Pre-SeedPre-seed | Healthtech, Biotech | Switzerland | Investors | |
| ET Develops novel therapies for beta globin disorders | $32M | GrantUndisclosed | Healthtech, Biotech | United States | Investors | |
| AT Amani TherapeuticsCompany profile Biotechnology company developing combination medicines for serious neuropsychiatric disorders. Biotechnology company developing combination medicines for serious neuropsychiatric disorders. | $25M | Series A | Healthtech, Biotech | United States | Investors | |
| FC Provides doula care for pregnant and postpartum patients. | $5.7M | Seed | Healthtech | United States | Investors | |
| C CarecubesCompany profile Develops isolation units to prevent infectious disease transmission in healthcare settings Develops isolation units to prevent infectious disease transmission in healthcare settings | $6.5M | Series A | Healthtech | United States | Investors | |
| P Develops AI agents to automate hospital administrative workflows | $20M | Series A | Healthtech | France | Investors | |
| HU Health UniverseCompany profile Provides AI infrastructure for healthcare organizations to integrate and govern autonomous agents Provides AI infrastructure for healthcare organizations to integrate and govern autonomous agents | $6M | Seed | Healthtech | United States | Investors | |
| ET Excalipoint TherapeuticsCompany profile Develops next-generation T-cell engager therapies for cancer and autoimmune diseases Develops next-generation T-cell engager therapies for cancer and autoimmune diseases | $27.7M | Seed+Seed | Healthtech, Biotech | China | Investors | |
| HL Automates data collection in hospital environments. | €2.1M | Seed | Healthtech | Spain | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →